TIGD5
gene geneOn this page
Also known as FLJ14926
Summary
TIGD5 (tigger transposable element derived 5, HGNC:18336) is a protein-coding gene on chromosome 8q24.3, encoding Tigger transposable element-derived protein 5 (Q53EQ6).
The protein encoded by this gene belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. These proteins are related to DNA transposons found in fungi and nematodes, and more distantly to the Tc1 and mariner transposases. They are also very similar to the major mammalian centromere protein B. The exact function of this gene is not known.
Source: NCBI Gene 84948 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 92 total — 1 pathogenic
- MANE Select transcript:
NM_032862
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18336 |
| Approved symbol | TIGD5 |
| Name | tigger transposable element derived 5 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14926 |
| Ensembl gene | ENSG00000179886 |
| Ensembl biotype | protein_coding |
| Entrez | 84948 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000504548
RefSeq mRNA: 1 — MANE Select: NM_032862
NM_032862
CCDS: CCDS6406
Canonical transcript exons
ENST00000321385 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 80.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.3569 / max 54.2742, expressed in 1645 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 91414 | 5.3569 | 1645 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.46 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.90 | gold quality |
| ventricular zone | UBERON:0003053 | 74.89 | gold quality |
| apex of heart | UBERON:0002098 | 74.51 | gold quality |
| cortical plate | UBERON:0005343 | 74.26 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.82 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.69 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 73.56 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.11 | gold quality |
| muscle of leg | UBERON:0001383 | 72.79 | gold quality |
| body of pancreas | UBERON:0001150 | 71.90 | gold quality |
| granulocyte | CL:0000094 | 71.73 | gold quality |
| heart left ventricle | UBERON:0002084 | 70.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 70.43 | gold quality |
| cerebellum | UBERON:0002037 | 70.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 70.23 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 70.21 | gold quality |
| right ovary | UBERON:0002118 | 70.07 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 70.05 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 69.94 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.08 | gold quality |
| lower esophagus | UBERON:0013473 | 69.08 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 69.07 | gold quality |
| fundus of stomach | UBERON:0001160 | 69.03 | gold quality |
| left ovary | UBERON:0002119 | 68.98 | gold quality |
| esophagus mucosa | UBERON:0002469 | 68.98 | gold quality |
| ovary | UBERON:0000992 | 68.96 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 68.96 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 68.83 | gold quality |
| pancreas | UBERON:0001264 | 68.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2562.1 | TIGD5 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605368
miRNA regulators (miRDB)
32 targeting TIGD5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-143-3P | 99.49 | 69.05 | 1457 |
| HSA-MIR-4770 | 99.49 | 69.09 | 1451 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-6088 | 99.29 | 68.45 | 1284 |
| HSA-MIR-6889-3P | 98.84 | 67.35 | 1198 |
| HSA-MIR-6529-3P | 98.68 | 66.76 | 1020 |
| HSA-MIR-3944-5P | 98.50 | 67.55 | 997 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-4733-3P | 98.35 | 65.20 | 994 |
| HSA-MIR-6511A-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-6511B-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-4640-5P | 97.42 | 66.33 | 1543 |
| HSA-MIR-4726-5P | 97.24 | 65.67 | 1299 |
| HSA-MIR-134-5P | 97.11 | 66.52 | 976 |
| HSA-MIR-3118 | 97.11 | 66.58 | 984 |
| HSA-MIR-1287-5P | 96.80 | 65.30 | 743 |
| HSA-MIR-6508-3P | 96.73 | 65.48 | 576 |
| HSA-MIR-6762-5P | 96.55 | 64.62 | 972 |
| HSA-MIR-6845-5P | 96.55 | 64.65 | 969 |
Literature-anchored findings (GeneRIF, showing 2)
- Comprehensive Integrative Analyses Identify TIGD5 rs75547282 as a Risk Variant for Autism Spectrum Disorder. (PMID:33393181)
- The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor. (PMID:36054307)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tigd5 | ENSMUSG00000103906 |
| rattus_norvegicus | Tigd5 | ENSRNOG00000008686 |
Paralogs (12): CENPB (ENSG00000125817), TIGD7 (ENSG00000140993), POGK (ENSG00000143157), POGZ (ENSG00000143442), TIGD6 (ENSG00000164296), TIGD4 (ENSG00000169989), TIGD3 (ENSG00000173825), TIGD2 (ENSG00000180346), JRKL (ENSG00000183340), TIGD1 (ENSG00000221944), JRK (ENSG00000234616), (ENSG00000293642)
Protein
Protein identifiers
Tigger transposable element-derived protein 5 — Q53EQ6 (reviewed: Q53EQ6)
All UniProt accessions (1): Q53EQ6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the tigger transposable element derived protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q53EQ6-1 | 1 | yes |
| Q53EQ6-2 | 2 |
RefSeq proteins (1): NP_116251* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004875 | DDE_SF_endonuclease_dom | Domain |
| IPR006600 | HTH_CenpB_DNA-bd_dom | Domain |
| IPR007889 | HTH_Psq | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR050863 | CenT-Element_Derived | Family |
Pfam: PF03184, PF03221, PF04218
UniProt features (21 total): compositionally biased region 5, domain 4, sequence conflict 4, region of interest 3, DNA-binding region 2, chain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53EQ6-F1 | 69.21 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 63 (showing top):
GOBP_SEGMENTATION, GOBP_SEGMENT_SPECIFICATION, ACEVEDO_LIVER_CANCER_UP, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, MARTENS_TRETINOIN_RESPONSE_DN, chr8q24, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ARID5B_TARGET_GENES, ASH1L_TARGET_GENES, GUCY1B1_TARGET_GENES, NCOA2_TARGET_GENES, SETD7_TARGET_GENES, SKIL_TARGET_GENES, SNRNP70_TARGET_GENES, ZMYM2_TARGET_GENES
GO Biological Process (2): segment specification (GO:0007379), central nervous system formation (GO:0021556)
GO Molecular Function (2): DNA binding (GO:0003677), nucleic acid binding (GO:0003676)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| pattern specification process | 1 |
| segmentation | 1 |
| central nervous system morphogenesis | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
414 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TIGD5 | COMMD5 | Q9GZQ3 | 658 |
| TIGD5 | PYCR3 | Q53H96 | 608 |
| TIGD5 | POGK | Q9P215 | 572 |
| TIGD5 | NAIF1 | Q69YI7 | 511 |
| TIGD5 | PEX39 | Q5I0X4 | 507 |
| TIGD5 | TRIM11 | Q96F44 | 486 |
| TIGD5 | CCDC24 | Q8N4L8 | 478 |
| TIGD5 | TIGD4 | Q8IY51 | 477 |
| TIGD5 | CENPBD1P | B2RD01 | 472 |
| TIGD5 | ZNF623 | O75123 | 449 |
| TIGD5 | ZHX1-C8orf76 | Q96EF9 | 447 |
| TIGD5 | POP1 | Q99575 | 447 |
| TIGD5 | ZNF285 | Q96NJ3 | 447 |
| TIGD5 | C8orf76 | Q96K31 | 445 |
| TIGD5 | SETMAR | Q53H47 | 444 |
IntAct
67 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NPHP1 | NPHP4 | psi-mi:“MI:0914”(association) | 0.930 |
| P4HA2 | P4HB | psi-mi:“MI:0914”(association) | 0.740 |
| P4HA3 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.640 |
| MAGEA4 | MAGEB16 | psi-mi:“MI:0914”(association) | 0.530 |
| HAVCR2 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| VSIG4 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| LTBR | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| EFNB2 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.530 |
| SPINT2 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.530 |
| DPPA4 | ALOX12B | psi-mi:“MI:0914”(association) | 0.530 |
| TIGD5 | P4HA2 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| TIGD5 | HSPA5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TIGD5 | P4HA2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNRD2 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRMT2 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| P3H1 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| NCAPH2 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| SKAP1 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| CDH5 | ARVCF | psi-mi:“MI:0914”(association) | 0.350 |
| THBS3 | APBB1 | psi-mi:“MI:0914”(association) | 0.350 |
| IKZF5 | PEX14 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (115): TIGD5 (Two-hybrid), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), P4HA2 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), TIGD5 (Affinity Capture-MS), ZMYND19 (Affinity Capture-MS)
ESM2 similar proteins: A0A061IR73, A0A1B0GUU1, A6H687, A8MYJ7, B1WC39, D3ZVB0, E1BD59, G3MY25, G3MZC5, O75064, P07199, P27790, P29597, P48988, P52333, P52824, Q08DF2, Q0VCE3, Q13608, Q1JPD6, Q2VPB7, Q3TAP4, Q3U1Y4, Q3ZBE0, Q499M4, Q53EQ6, Q5JZY3, Q62137, Q63272, Q6B0B8, Q6DI92, Q6ZPS2, Q6ZS72, Q7TM95, Q80VI1, Q86UT6, Q8BYG9, Q8N9M5, Q8R5G7, Q8TE96
Diamond homologs: B0X560, B1WC39, G3MY25, Q16IB4, Q29CW0, Q29CW2, Q499M4, Q53EQ6, Q9VBW6, Q9VBW9, Q60976, Q9Y4A0, B2RD01, B2RRL2, O75564, Q0VBL1, Q4W5G0, Q6NT04
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
92 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 89 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 815175 | GRCh37/hg19 8q24.3(chr8:143616831-144930611)x1 | Pathogenic |
SpliceAI
130 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:143599489:TTGCG:T | donor_gain | 0.9600 |
| 8:143599485:G:GT | donor_gain | 0.9400 |
| 8:143599648:GGACC:G | donor_gain | 0.9200 |
| 8:143599490:TGCGG:T | donor_gain | 0.9100 |
| 8:143599541:G:GT | donor_gain | 0.9000 |
| 8:143599542:G:T | donor_gain | 0.9000 |
| 8:143599751:GC:G | donor_gain | 0.8800 |
| 8:143599509:G:GT | donor_gain | 0.8300 |
| 8:143599545:G:GT | donor_gain | 0.7900 |
| 8:143599407:G:GT | donor_gain | 0.7700 |
| 8:143599645:G:GT | donor_gain | 0.7400 |
| 8:143599828:T:A | donor_gain | 0.7100 |
| 8:143599519:G:GT | donor_gain | 0.6800 |
| 8:143599719:G:GT | donor_gain | 0.6500 |
| 8:143599491:GCGGA:G | donor_gain | 0.6400 |
| 8:143599524:C:A | donor_gain | 0.6200 |
| 8:143599269:G:GT | donor_gain | 0.5800 |
| 8:143599649:GACC:G | donor_gain | 0.5700 |
| 8:143599726:GAGAG:G | donor_gain | 0.5700 |
| 8:143599670:G:T | donor_gain | 0.5600 |
| 8:143599813:GCCCC:G | donor_gain | 0.5600 |
| 8:143599550:G:GA | donor_gain | 0.5400 |
| 8:143599551:G:A | donor_gain | 0.5200 |
| 8:143599728:G:GT | donor_gain | 0.5200 |
| 8:143599827:G:A | donor_gain | 0.5200 |
| 8:143599873:G:GT | donor_gain | 0.5200 |
| 8:143599493:G:GT | donor_gain | 0.5000 |
| 8:143599746:C:T | donor_gain | 0.5000 |
| 8:143602878:G:T | acceptor_gain | 0.5000 |
| 8:143600402:ACTGG:A | donor_gain | 0.4900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000551410 (8:143597910 C>A), RS1000848682 (8:143602271 G>T), RS1001156173 (8:143598513 A>C,G), RS1001505088 (8:143595932 C>T), RS1001598335 (8:143596177 T>A), RS1001790227 (8:143598779 G>A), RS1001884430 (8:143602770 C>A,G,T), RS1002290547 (8:143597889 C>A,T), RS1002601339 (8:143597252 C>T), RS1002906562 (8:143600727 A>C), RS1003498766 (8:143601782 G>A), RS1003569404 (8:143602773 C>T), RS1003852521 (8:143601648 C>G), RS1004161478 (8:143603489 G>GTGGC), RS1004517533 (8:143603439 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006804_50 | Red cell distribution width | 1.000000e-13 |
| GCST008459_52 | Schizophrenia | 4.000000e-08 |
| GCST008459_53 | Schizophrenia | 1.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009188 | Red cell distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | affects sumoylation | 1 |
| propylparaben | increases expression | 1 |
| lead acetate | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| cupric chloride | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | decreases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Cadmium | increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.